Filed Pursuant to Rule 424(b)(5)
Registration No. 333-220459
Amendment No. 2 dated August 6, 2020
(To prospectus supplement dated December 11, 2017,
as amended by Amendment No. 1 dated August 3, 2018,
and prospectus dated September 28, 2017)
Up to $100,000,000
Common Stock
This Amendment No. 2 (this “amendment”) amends our prospectus supplement dated December 11, 2017, as amended by Amendment No. 1 dated August 3, 2018 (as amended by Amendment No. 1 and this amendment, the “prospectus supplement”), and the prospectus dated September 28, 2017 (the “accompanying prospectus”). This amendment should be read in conjunction with the prospectus supplement and the accompanying prospectus, including the documents incorporated by reference herein and therein, each of which are to be delivered with this amendment. Except as set forth in this amendment, the prospectus supplement and the accompanying prospectus, as updated by the documents incorporated by reference herein and therein, remain unchanged.
On August 6, 2020, we entered into an amendment to the equity distribution agreement, dated December 11, 2017, with UBS Securities LLC and an equity distribution agreement with RBC Capital Markets, LLC, relating to the shares of our common stock, par value $0.01 per share (“Common Stock”), offered by the prospectus supplement and the accompanying prospectus. We refer to UBS Securities LLC and RBC Capital Markets, LLC, when acting in their capacity as sales agents, individually as a “sales agent” and collectively as “sales agents,” and refer to the equity distribution agreements (as amended) with each of UBS Securities LLC and RBC Capital Markets, LLC as the “equity distribution agreements.”
In accordance with the terms of the equity distribution agreements, we may offer and sell, from time to time, shares of our Common Stock, having an aggregate offering price of up to $100,000,000 through the sales agents (which amount includes shares we have already sold pursuant to the prospectus supplement prior to the date of this amendment). As of the date of this amendment, we have sold shares of our Common Stock having an aggregate offering price of $15,500,000 pursuant to the prospectus supplement and the accompanying prospectus.
Our Common Stock is listed on the New York Stock Exchange (“NYSE”) under the symbol “AHT.” On August 5, 2020, the last reported sales price of our Common Stock on the NYSE was $4.06 per share.
Sales of our Common Stock, if any, pursuant to the prospectus supplement, and the accompanying prospectus may be made in negotiated transactions, which may include block trades, or transactions that are deemed to be “at-the-market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange.
Subject to the terms and conditions of the equity distribution agreements, the sales agents are not required to sell any specific number or dollar amount of shares, but upon acceptance of a placement notice from us, the sales agents will use commercially reasonable efforts, consistent with its normal trading and sales practices, to sell the shares offered by the prospectus supplement, and the accompanying prospectus on the terms set forth in the placement notice. The sales agents will receive from us a commission that will not exceed, but may be lower than, 2.0% of the gross sales price of all shares sold through it as sales agent under the applicable equity distribution agreement. In connection with any sales of Common Stock on our behalf, the sales agents may be deemed to be “underwriters” within the meaning of the Securities Act, and the compensation paid to the sales agents may be deemed to be underwriting commissions or discounts. See “Plan of Distribution” in this amendment and the prospectus supplement.
We also may sell some or all of the shares of Common Stock to a sales agent as principal for its own account at a price agreed upon at the time of sale. If we sell Common Stock to a sales agent as principal, then we will enter into a separate terms agreement with such sales agent, and the sale will be made pursuant to the terms thereunder.
Our Common Stock is subject to certain restrictions on ownership designed to preserve our qualification as a real estate investment trust (“REIT”) for federal income tax purposes. See “Description of our Capital Stock — Restrictions on Ownership and Transfer” in the accompanying prospectus.
Investing in our Common Stock involves a high degree of risk. Risks associated with an investment in our Common Stock are described under the heading “Risk Factors” on page S-9 of this amendment and in our Annual Report on Form 10-K for the year ended December 31, 2019 filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as updated by our subsequent filings under the Exchange Act, which are incorporated by reference into this amendment, the prospectus supplement and the accompanying prospectus. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities, or determined if this amendment, the prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| UBS Investment Bank | | | RBC Capital Markets | |
The date of this Amendment No. 2 to Prospectus Supplement is August 6, 2020